Physician profile
Carley Thomas
NPI 1265038814
$1,472.56
in general payments reported to CMS, 2019-2025
9 companies · $73.00 in 2025
The $73.00 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $596 · 2023: $550 · 2024: $254 · 2025: $73.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $352.05 | 2022-2023 | Collagenase Santyl, Acticoat 4" X 4", Oasis |
| Avita Medical Americas, LLC | $328.87 | 2023-2025 | Recell, Cohealyx, Permeaderm |
| Integra Lifesciences Corporation | $273.41 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $192.69 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Polynovo North America LLC | $116.34 | 2022 | |
| Kci USA, INC. | $96.49 | 2022 | |
| Mimedx Group, INC. | $48.20 | 2024-2025 | |
| Csl Behring | $43.78 | 2023-2024 | Kcentra |
| Solventum Corporation | $20.73 | 2025 | V.A.C. Veraflo Cleanse Choice |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carley Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.